Asymchem Laboratories(Tianjin)Co.,Ltd.(002821),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

002821 Asymchem Laboratories(Tianjin)Co.,Ltd.

Closed 05-07 15:00:00

128.08

+3.40

+2.73%

High131.29	Low124.98	Vol7.83M
Open124.98	D1 Closing124.68	Amplitude5.06%
Mkt Cap46.24B	Tradable Cap40.60B	Total Shares361.00M
T/O1.01B	T/O Rate2.47%	Tradable Shares317.00M
P/B2.51	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"002821","market":"SZ","secType":"STK","nameCN":"Asymchem Laboratories(Tianjin)Co.,Ltd.","latestPrice":128.08,"timestamp":1778137386000,"preClose":124.68,"halted":0,"volume":7829843,"delay":0,"changeRate":0.0273,"floatShares":317000000,"shares":361000000,"eps":3.0767,"marketStatus":"Closed","change":3.4,"latestTime":"05-07 15:00:00","open":124.98,"high":131.29,"low":124.98,"amount":1007000000,"amplitude":0.0506,"askPrice":128.09,"askSize":3,"bidPrice":128.08,"bidSize":20,"shortable":0,"etf":0,"ttmEps":3.0767,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1778203800000},"marketStatusCode":5,"adr":0,"adjPreClose":124.68,"symbolType":"stock","openAndCloseTimeList":[[1778117400000,1778124600000],[1778130000000,1778137200000]],"highLimit":137.15,"lowLimit":112.21,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":360874970,"isCdr":false,"pbRate":2.51,"roa":"--","peRate":41.629018,"roe":"1.71%","epsLYR":3.16,"committee":0.611374,"marketValue":46221000000,"turnoverRate":0.0247,"status":0,"hkstockBrief":{"symbol":"06821","market":"HK","secType":"STK","nameCN":"ASYMCHEM","latestPrice":105.6,"timestamp":1778141291007,"preClose":98.85,"halted":0,"volume":690140,"delay":0,"premium":"-28.42"},"floatMarketCap":40607000000},"requestUrl":"/m/hq/s/002821/wiki","defaultTab":"wiki","newsList":[{"id":"2633913791","title":"Citigroup's Long Position in H-Shares of Asymchem Laboratories (Tianjin)  Decreases to 7.11% on Apr 28 From 9.86% - HKEX","url":"https://stock-news.laohu8.com/highlight/detail?id=2633913791","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633913791?lang=en_us&edition=fundamental","pubTime":"2026-05-05 17:32","pubTimestamp":1777973520,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nFWN41I0JO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["002821","LU1328615791.USD","BK1191","06821","BK0132","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632956860","title":"BRIEF-JPMorgan Chase’s Long Position In H-Shares Of Asymchem Laboratories (Tianjin) Decreases To 7.64% On Apr 28 From 8.18%, HKEX Filing Shows","url":"https://stock-news.laohu8.com/highlight/detail?id=2632956860","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632956860?lang=en_us&edition=fundamental","pubTime":"2026-05-04 21:20","pubTimestamp":1777900826,"startTime":"0","endTime":"0","summary":"BRIEF-JPMorgan Chase’s Long Position In H-Shares Of Asymchem Laboratories  Decreases To 7.64% On Apr 28 From 8.18%, HKEX Filing ShowsMay 4  - HKEX:JPMORGAN CHASE’S LONG POSITION IN H-SHARES OF ASYMCHEM LABORATORIES  6821.HK DECREASES TO 7.64% ON APRIL 28 FROM 8.18%Further company coverage: 6821.HK ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nFWN41H06C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1328615791.USD","06821","002821","BK0239","BK0132","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632311239","title":"JPMorgan Chase’s Long Position in H-Shares of Asymchem Laboratories (Tianjin)  Decreases to 7.64% on April 28 From 8.18% - HKEX Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2632311239","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632311239?lang=en_us&edition=fundamental","pubTime":"2026-05-04 17:26","pubTimestamp":1777886805,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nFWN41H06C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","002821","BK0132","LU1328615791.USD","BK0239","06821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155715250","title":"Schroders PLC Reduces Stake in Asymchem by 258,900 Shares at HK$113.53 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=1155715250","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155715250?lang=en_us&edition=fundamental","pubTime":"2026-04-30 08:10","pubTimestamp":1777507849,"startTime":"0","endTime":"0","summary":"According to the latest data from the Hong Kong Stock Exchange, Schroders PLC sold 258,900 shares of Asymchem (06821) on April 28 at a price of HK$113.5268 per share. The total transaction value...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["002821","LU1328615791.USD","EWH","BK0239","06821","BK0132","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187897321","title":"Norges Bank Reduces Stake in Asymchem by 184,900 Shares at HK$102.86 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=1187897321","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187897321?lang=en_us&edition=fundamental","pubTime":"2026-04-29 21:09","pubTimestamp":1777468147,"startTime":"0","endTime":"0","summary":"According to the latest data from the Hong Kong Stock Exchange, on April 27, Norges Bank sold 184,900 shares of Asymchem (06821) at a price of HK$102.8593 per share, totaling approximately HK$19.02...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1328615791.USD","06821","EWH","BK0239","BK0132","BK1191","002821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114745508","title":"Bocom International Raises Asymchem's Target Price to HK$136.6, Keeps Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=1114745508","media":"Stock News","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114745508?lang=en_us&edition=fundamental","pubTime":"2026-04-29 10:54","pubTimestamp":1777431256,"startTime":"0","endTime":"0","summary":"Bocom International has increased its target price for Asymchem's H-shares to HK$136.6, while setting the A-share target at RMB 159.2, maintaining a \"Buy\" rating. Following stronger-than-expected...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","BK1191","LU1328615791.USD","BK0132","06821","EWH","002821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170783166","title":"Asymchem Laboratories Shareholder Transfers HK$177 Million Stake from Citibank to Morgan Stanley Hong Kong Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=1170783166","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170783166?lang=en_us&edition=fundamental","pubTime":"2026-04-29 08:36","pubTimestamp":1777422997,"startTime":"0","endTime":"0","summary":"On April 28, a shareholder of Asymchem Laboratories transferred shares from Citibank to Morgan Stanley Hong Kong Securities, with a total transfer value of HK$177 million, accounting for 6.06% of the...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1267930227.SGD","LU1668664300.SGD","LU1720051017.SGD","LU2023251221.USD","BK0132","LU0971096721.USD","BK4127","06821","BK4585","LU0795875086.SGD","BK1191","BK4566","LU2456880835.USD","LU0158827781.USD","LU1720051108.HKD","LU1989772840.SGD","LU2133065610.SGD","LU2089284900.SGD","LU1366192091.USD","LU1363072403.SGD","LU0234570918.USD","LU0130517989.USD","LU1989772923.USD","LU0310800965.SGD","LU2236285917.USD","LU0314104364.USD","LU0106831901.USD","LU0477156953.USD","LU2125154935.USD","LU2028103732.USD","BK4559","LU2271345857.HKD","IE00BSNM7G36.USD","LU2089283258.USD","BK0239","LU0980610538.SGD","BK4207","LU0320765646.SGD","LU0314106906.USD","MS","BK4588","LU2357305700.SGD","LU2125154778.USD","LU1162221912.USD","LU0225283273.USD","BK4504","LU0528227936.USD","LU2347655156.SGD","LU0912757837.SGD","LU0052756011.USD","LU1328615791.USD","LU0648001328.SGD","LU1244550577.SGD","BK4581","IE00BZ1G4Q59.USD","LU1791710582.SGD","LU0130102774.USD","LU2111349929.HKD","LU0557290698.USD","LU0170899867.USD","161027","LU2360032135.SGD","LU1791807156.HKD","LU0267386448.USD","LU1244550221.USD","LU0882574139.USD","LU2417539215.USD","LU0158827948.USD","BK4516","LU0128525689.USD","LU1506573853.SGD","LU1732800096.USD","LU0162691827.USD","LU1732799900.SGD","LU0072461881.USD","LU0098860793.USD","IE00BKVL7J92.USD","C","LU1791710400.SGD","LU1244550494.USD","LU0106261372.USD","LU0006306889.USD","LU1548497426.USD","LU2462157665.USD","LU0795875169.SGD","BK4534","LU1201861249.SGD","002821","LU1074936037.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630325257","title":"Asymchem Laboratories' Profit Falls 6.8% in Q1; Shares Rise 8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630325257","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630325257?lang=en_us&edition=fundamental","pubTime":"2026-04-28 12:18","pubTimestamp":1777349912,"startTime":"0","endTime":"0","summary":"Asymchem Laboratories  posted a net profit attributable to shareholders of 304.3 million yuan for the first quarter, down 6.8% from 326.6 million yuan a year earlier, according to a Monday Hong Kong bourse filing.Hong Kong-listed shares of the pharmaceutical outsourcing services firm were up nearly 8% in Tuesday's midday trade.Earnings per share came in at 0.84 yuan, compared with 0.89 yuan in the prior-year period.Revenue rose 17% to 1.80 billion yuan from 1.54 billion yuan a year earlier.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1191","002821","LU1328615791.USD","06821","BK0132","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146374759","title":"Asymchem Laboratories Surges Over 10% on Strong Q1 Adjusted Net Profit Growth and Emerging Business Revenue Jump","url":"https://stock-news.laohu8.com/highlight/detail?id=1146374759","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146374759?lang=en_us&edition=fundamental","pubTime":"2026-04-28 11:26","pubTimestamp":1777346782,"startTime":"0","endTime":"0","summary":"Asymchem Laboratories (06821) saw its shares rise more than 10%, reaching a price of HK$115.5 at the time of writing, with a trading volume of HK$172 million. The surge follows the company's release...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"80c6b79ff83106ff1da4986263b7db82","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0132","BK4585","VXUS","06821","002821","BK1191","BK4588","BK0239","LU1328615791.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630910303","title":"Asymchem Q1 net profit drops 6.82% to RMB 304.32 million; revenue rises 16.91% to RMB 1.8 billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2630910303","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630910303?lang=en_us&edition=fundamental","pubTime":"2026-04-27 20:59","pubTimestamp":1777294797,"startTime":"0","endTime":"0","summary":"Asymchem reported Q1 2026 net profit attributable to shareholders of RMB 304.32 million, down 6.82%.Emerging business revenue climbed 74.07% to RMB 598 million, while small molecule CDMO revenue edged up 0.43% to RMB 1.2 billion.Profit decline was attributed to higher foreign exchange losses from RMB appreciation, versus exchange gains a year earlier.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Asymchem Laboratories Tianjin Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 27, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nNDL1GpT1q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0132","BK0239","LU1328615791.USD","002821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630678293","title":"BRIEF-Asymchem Laboratories (Tianjin) Q1 Net Profit Down 6.8% Y/Y","url":"https://stock-news.laohu8.com/highlight/detail?id=2630678293","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630678293?lang=en_us&edition=fundamental","pubTime":"2026-04-27 18:18","pubTimestamp":1777285095,"startTime":"0","endTime":"0","summary":"BRIEF-Asymchem Laboratories (Tianjin) Q1 Net Profit Down 6.8% Y/YApril 27 (Reuters) - Asymchem Laboratories (Tianjin) Co Ltd 002821.SZ:Q1 NET PROFIT DOWN 6.8% Y/YSource textFurther company coverage: 002821.SZ (Reporting by Beijing Newsroom) ((Shi.Bu@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nL4N41A0T9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1328615791.USD","BK0132","002821","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129816256","title":"Goldman Sachs Maintains Positive Outlook on China's CDMO Sector, Favors WuXi AppTec and Asymchem","url":"https://stock-news.laohu8.com/highlight/detail?id=1129816256","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129816256?lang=en_us&edition=fundamental","pubTime":"2026-04-27 17:42","pubTimestamp":1777282947,"startTime":"0","endTime":"0","summary":"Goldman Sachs has released a research report on China's pharmaceutical industry, indicating that the performance of CDMO enterprises reflects the sector's sustained stability. Visibility is...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1328615791.USD","LU1808992512.USD","LU1969619763.USD","603259","BK1576","02359","BK1191","BK1589","BK1617","LU2495084118.USD","LU0348767384.USD","BK4139","BK1585","LU0348766576.USD","LU2242644610.SGD","LU1979443071.USD","LU1997245177.USD","LU2045819591.USD","LU0456842615.SGD","06821","LU1934453819.USD","01066","CDMO","LU1997244956.HKD","LU0173614495.USD","LU0320764599.SGD","LU2125910500.SGD","002821","BK0132","LU0052750758.USD","BK1222","BK1583","LU1046422090.SGD","LU2488822045.USD","02252","BK0239","LU1997245094.SGD","LU0708995583.HKD","BK1100","BK1141","BK0216","LU0287142896.SGD","LU2328871848.SGD","02675","01789"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118017872","title":"Asymchem Shares Surge Over 5% in Late Trading as Major TIDES CDMO Project Launches in Tianjin","url":"https://stock-news.laohu8.com/highlight/detail?id=1118017872","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118017872?lang=en_us&edition=fundamental","pubTime":"2026-04-27 15:48","pubTimestamp":1777276101,"startTime":"0","endTime":"0","summary":"Asymchem Laboratories (Tianjin) Co., Ltd. (06821) saw its shares rise more than 5% in late trading. At the time of writing, the stock had advanced 5.13% to HK$104.5, with a turnover of HK$118...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1328615791.USD","BK0132","BK4588","BK4139","CDMO","BK1191","002821","BK4585","VXUS","06821","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173537758","title":"Asymchem Shares Surge Nearly 6% Afternoon Following Launch of 2 Billion Yuan Macromolecule Drug CDMO Project in Tianjin","url":"https://stock-news.laohu8.com/highlight/detail?id=1173537758","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173537758?lang=en_us&edition=fundamental","pubTime":"2026-04-24 14:28","pubTimestamp":1777012101,"startTime":"0","endTime":"0","summary":"Asymchem (06821) rose nearly 6% in afternoon trading. At the time of writing, the stock was up 5.49%, trading at HK$97.1, with a turnover of HK$44.5826 million. The increase follows news that...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159992","BK0132","BK4588","BK1161","06821","BK0239","LU1328615791.USD","BK1574","002821","VXUS","BK4585","BK1191","CDMO","06978","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629322701","title":"Asymchem Laboratories Profit Rises 19% in 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2629322701","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629322701?lang=en_us&edition=fundamental","pubTime":"2026-04-21 12:07","pubTimestamp":1776744477,"startTime":"0","endTime":"0","summary":"Asymchem Laboratories  posted a net profit attributable to shareholders of 1.13 billion yuan for 2025, up 19% from 949.0 million yuan a year earlier, according to a Monday Hong Kong bourse filing.Hong Kong-listed shares of the pharmaceutical outsourcing services firm lost nearly 2% in Tuesday morning trade.Earnings per share came in at 3.16 yuan, compared with 2.69 yuan in the prior year.Revenue rose 15% to 6.67 billion yuan from 5.80 billion yuan in 2024.The board proposed a final dividend of 13 yuan per 10 shares.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0132","BK0239","002821","LU1328615791.USD","BK1191","06821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155453128","title":"Norges Bank Increases Stake in Asymchem Laboratories by 85,300 Shares at HK$98.94 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=1155453128","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155453128?lang=en_us&edition=fundamental","pubTime":"2026-04-20 19:40","pubTimestamp":1776685254,"startTime":"0","endTime":"0","summary":"On April 17, Norges Bank purchased an additional 85,300 shares of Asymchem Laboratories (06821) at a price of HK$98.9427 per share. The total transaction value amounted to approximately HK$8.44...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1328615791.USD","002821","06821","BK0132","EWH","BK0239","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628476777","title":"Asymchem Tianjin publishes 2025 annual report","url":"https://stock-news.laohu8.com/highlight/detail?id=2628476777","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628476777?lang=en_us&edition=fundamental","pubTime":"2026-04-20 19:32","pubTimestamp":1776684770,"startTime":"0","endTime":"0","summary":"Asymchem published 2025 annual report, highlighting recovery in CDMO demand with double-digit revenue growth.Order backlog reached USD 1.4 billion, supported by rapid expansion in chemical macromolecule CDMO and biological macromolecule CDMO.Emerging businesses scaled up, led by peptides and oligonucleotides, with overseas revenue in these segments rising more than 240%.Commercial execution broadened with first peptide project moving into commercial supply, while first ADC drug entered commercialization following pre-approval inspection clearance.Capacity buildout continued, including peptide synthesis capacity set to rise to 69,000 L by end-2026, while oligonucleotide capacity is projected to reach 180 mol by end-June 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as fin","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nNDL2mk5fM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["002821","BK0239","LU1328615791.USD","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628207889","title":"Asymchem Laboratories held extraordinary general meeting to vote on share repurchase, articles changes","url":"https://stock-news.laohu8.com/highlight/detail?id=2628207889","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628207889?lang=en_us&edition=fundamental","pubTime":"2026-04-17 22:25","pubTimestamp":1776435943,"startTime":"0","endTime":"0","summary":"Asymchem Laboratories held its first extraordinary general meeting of 2026 on April 17, 2026.Shareholders adopted two resolutions to repurchase and cancel part of restricted A shares granted under 2025 A Share Scheme, covering repurchase-and-cancellation proposals dated Dec. 19, 2025, and March 13, 2026.Meetings also passed amendments to Articles of Association, with changes taking immediate effect.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Asymchem Laboratories Tianjin Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 17, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260417:nNDL80s2qt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","LU1328615791.USD","BK0132","002821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191346325","title":"Asymchem Laboratories Expands TIDES Production Capacity, Enhancing Drug Service Capabilities","url":"https://stock-news.laohu8.com/highlight/detail?id=1191346325","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191346325?lang=en_us&edition=fundamental","pubTime":"2026-04-16 14:31","pubTimestamp":1776321113,"startTime":"0","endTime":"0","summary":"On April 14, the Administrative Committee of Tianjin Economic-Technological Development Area signed a cooperation memorandum with Asymchem Laboratories (Tianjin) Co., Ltd. to continuously expand the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1328615791.USD","BK0132","BK0239","06821","BK1191","002821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130637500","title":"J.P. Morgan Increases Stake in Asymchem by 95,600 Shares at HK$97.68 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=1130637500","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130637500?lang=en_us&edition=fundamental","pubTime":"2026-04-14 07:50","pubTimestamp":1776124249,"startTime":"0","endTime":"0","summary":"Latest data from the Hong Kong Stock Exchange shows that on April 8, J.P. Morgan increased its holding in Asymchem (06821) by 95,600 shares. The transaction was executed at a price of HK$97.6752 per...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1551013342.USD","LU2756315318.SGD","LU0106261372.USD","LU0868494617.USD","LU1720051108.HKD","LU2746668461.USD","BK4534","LU2746668974.SGD","LU1244550494.USD","LU2505996509.AUD","IE00BDRTCR15.USD","LU1496350171.SGD","LU2357305700.SGD","LU2237443549.SGD","LU1244550577.SGD","LU0820562030.AUD","LU2237443382.USD","LU0070302665.USD","EWH","BK0132","BK4504","IE00BN8TJ469.HKD","BK4588","LU0323591593.USD","LU0203347892.USD","LU0106831901.USD","LU2211815571.USD","LU1145028129.USD","LU0238689110.USD","LU2237443895.HKD","LU2430703095.HKD","IE00BFXG1179.USD","IE0034235188.USD","LU0211326839.USD","IE00BWXC8680.SGD","LU1548497426.USD","LU0203345920.USD","BK4550","IE0034235295.USD","LU1116320901.HKD","LU2430703251.USD","BK4516","LU0345769631.USD","LU2381873111.SGD","IE00BBT3K403.USD","LU0640476718.USD","LU0251132253.USD","IE0034235303.USD","LU2430703178.SGD","LU0048584097.USD","LU1119994496.HKD","LU1551013425.SGD","LU0211328371.USD","LU0976567544.SGD","LU1328615791.USD","LU1280957306.USD","JPO","LU0211326755.USD","LU0211327993.USD","LU0882574139.USD","LU1032466523.USD","IE00B1BXHZ80.USD","IE00BJLML261.HKD","LU0787776722.HKD","BK4581","LU2106854487.HKD","LU1366192091.USD","LU1244550221.USD","LU2237443622.USD","LU1914381329.SGD","LU1162221912.USD","LU2592432038.USD","LU2756315664.SGD","IE00BKDWB100.SGD","LU0211331839.USD","LU0265550359.USD","LU2237443465.HKD","LU2237443978.SGD","IE00BZ1G4Q59.USD","LU0971096721.USD","LU0320765489.SGD","SG9999002224.SGD","LU2456880835.USD","LU0310799852.SGD","LU1988902786.USD","BK4585","LU2213496289.HKD","LU0943347566.SGD","LU1974910355.USD","LU1670627923.USD","LU0215105999.USD","LU0265550946.USD","LU0256863811.USD","LU1064131342.USD","LU0345769128.USD","LU0345770308.USD","LU0320765646.SGD","LU0868494708.USD","IE00B775SV38.USD","LU2023250330.USD","BK0239","LU0689472784.USD","LU0683600562.USD","LU1084165304.USD","LU0267386448.USD","LU0496365809.HKD","LU2264538146.SGD","LU2505996681.GBP","JPMO","LU0234572021.USD","LU1670628061.USD","IE00BKVL7J92.USD","LU2462157665.USD","002821","LU1496350502.SGD","LU2417539215.USD","LU1894683264.USD","IE00BYXW3230.USD","LU0345770993.USD","LU2023250843.SGD","IE00BLSP4239.USD","JPM","LU1917777945.USD","IE00B3S45H60.SGD","LU0208291251.USD","LU1668664300.SGD","LU1720051017.SGD","IE00BJTD4N35.SGD","LU2552382215.SGD","SG9999002232.USD","LU0417517546.SGD","LU1116320737.USD","BK4207","LU1267930490.SGD","06821","LU0964807845.USD","LU1363072403.SGD","LU0149725797.USD","LU2242649171.HKD","LU2552382058.USD","IE000M9KFDE8.USD","LU0170899867.USD","LU1629891620.HKD","BK4533","BK1191","BK4566","LU1261432733.SGD","IE00BDCRKT87.USD","LU2552382132.HKD","LU2054465674.USD","LU0820561818.USD","LU1894683348.USD","LU0006306889.USD","LU2023250504.SGD","LU0820561909.HKD","IE00B1XK9C88.USD","IE00BHPRN162.USD","IE00BJTD4V19.USD","LU2236285917.USD","IE00BLSP4452.SGD","LU0942090050.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2016-11-18","address":"天津市滨海新区经济技术开发区洞庭三街6号","stockEarnings":[{"period":"1week","weight":-0.0167},{"period":"1month","weight":0.0215},{"period":"3month","weight":0.2164},{"period":"6month","weight":0.3098},{"period":"1year","weight":0.5213},{"period":"ytd","weight":0.3417}],"companyName":"凯莱英医药集团(天津)股份有限公司","boardCode":"AI0027","perCapita":"--","boardName":"医药制造业","registeredCapital":"36087万元","compareEarnings":[{"period":"1week","weight":0.0128},{"period":"1month","weight":0.0722},{"period":"3month","weight":0.0207},{"period":"6month","weight":0.0407},{"period":"1year","weight":0.2545},{"period":"ytd","weight":0.0482}],"survey":"　　凯莱英医药集团(天津)股份有限公司的主营业务是为国内外制药公司、生物技术公司提供药品全生命周期的一站式服务。公司的主要产品是小分子CDMO解决方案、新兴业务。凯莱英生物AsymBio偶联药物开发平台成功入围第12届WorldADCAwards“BestADCPlatformTechnology”奖项，印证了凯莱英生物在全球抗体偶联药物CDMO领域的卓越地位。","serverTime":1778146000976,"listedPrice":30.53,"stockholders":"0人","compareStock":{"symbol":"000001.SH","name":"SSE Comp"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Asymchem Laboratories(Tianjin)Co.,Ltd.(002821),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Asymchem Laboratories(Tianjin)Co.,Ltd.(002821) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Asymchem Laboratories(Tianjin)Co.,Ltd.,002821,Asymchem Laboratories(Tianjin)Co.,Ltd.股票,Asymchem Laboratories(Tianjin)Co.,Ltd.股票老虎,Asymchem Laboratories(Tianjin)Co.,Ltd.股票老虎国际,Asymchem Laboratories(Tianjin)Co.,Ltd.行情,Asymchem Laboratories(Tianjin)Co.,Ltd.股票行情,Asymchem Laboratories(Tianjin)Co.,Ltd.股价,Asymchem Laboratories(Tianjin)Co.,Ltd.股市,Asymchem Laboratories(Tianjin)Co.,Ltd.股票价格,Asymchem Laboratories(Tianjin)Co.,Ltd.股票交易,Asymchem Laboratories(Tianjin)Co.,Ltd.股票购买,Asymchem Laboratories(Tianjin)Co.,Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Asymchem Laboratories(Tianjin)Co.,Ltd.(002821),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Asymchem Laboratories(Tianjin)Co.,Ltd.(002821) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}